Private Profits versus Public Policy : : The Pharmaceutical Industry and the Canadian State / / Joel Lexchin.
The widespread condemnation of drastic price increases on life-saving drugs highlights our growing dependency on and vulnerability to international pharmaceutical conglomerates. However, aren’t the interests of the public supposed to supersede the pursuit of private profit?In his new work, Private P...
Saved in:
| Superior document: | Title is part of eBook package: De Gruyter University of Toronto Press Complete eBook-Package 2016 |
|---|---|
| VerfasserIn: | |
| Place / Publishing House: | Toronto : : University of Toronto Press, , [2018] ©2016 |
| Year of Publication: | 2018 |
| Language: | English |
| Online Access: | |
| Physical Description: | 1 online resource (384 p.) :; 6 figures |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Table of Contents:
- Frontmatter
- Contents
- List Of Boxes, Figures, And Tables
- Preface
- Abbreviations
- Private Profits Versus Public Policy The Pharmaceutical Industry And The Canadian State
- Introduction: Why Do We Care About The Pharmaceutical Industry In Canada?
- 1.(De)Regulation Through Cooperation
- 2. Biased Testing, Hidden Results, And The Regulation Of Clinical Trials
- 3. Approving New Drugs: Better Or Just More?
- 4. Regulating Promotion Or Licensing Deception?
- 5. Health Canada And Drug Safety: How Safe Are We?
- 6. Is Intellectual Property A Right?
- 7. How Revenue Is Generated: Prices, Volume, Mix, And Overall Spending
- 8. Who Gets The Value From Research And Development?
- 9. Canada, The Pharmaceutical Industry, And Access To Medicines In The Global South
- 10. Courage, My Friends; ’Tis Not Too Late To Build A Better World
- Acknowledgments
- References
- Index